This event already occurred. Enjoy the recording!
GleeT1D is a nationwide effort to study the effect of Gleevec on people newly diagnosed with type 1 diabetes. This study will help medical researchers determine if a short-term course of medication can have a long-term effect on the body’s ability to preserve and make insulin-producing beta cells.
Come hear Mike Lawson interview Dr. Gitelman about this study and the value of clinical trials.